NYSE · YSS

York Space Systems Inc.

$17.06 -$0.56 (-3.18%) 1D After hours

Key Metrics

$2.32B
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow
Beta · 1Y 2.27
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    From its Apr 22 high, the share price fell 61%.

    Peak close $43.45 on Apr 22; trough close $17.06 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -61%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 11
    The stock moved +22.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 11
  • Apr 9
    The stock moved +28.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 9

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.32B
Enterprise value$1.81B
Shares outstanding131.4M
52-wk range$16.53 – $44.54
Avg volume · 20D2.0M
Net cash $507.82M
Book value / share$13.11
IndustryGuided Missiles & Space Vehicles & Parts
ExchangeNYSE
About York Space Systems Inc.
IPO dateJan 29, 2026
Employees710

York Space Systems Inc is a U.S.-based space and defense company that provides mission-related solutions for national security, government, and commercial customers.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio5.53
Quick ratio5.29
Debt / equity0.09
Debt / EBITDA
Net cash $507.82M
Working capital$664.81M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

Needs two fiscal years of filings

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings